ArticleCommunications biology2026

Targeting IRF1-TRIM21 axis enhances anti-tumor immunity by promoting ubiquitin-mediated degradation of FGL1 in non-small cell lung cancer.

Yuchen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.